![Graphic][1] Following the July publication of the Cumberlege review, the ABN met with Dr June Raine (Chief Executive of the MHRA) and colleagues to discuss next steps including the possibility of developing a valproate register. The MHRA team were very well briefed on the topic. ABN explained the need for research to better understand the information given to women who become pregnant while taking valproate, and the basis for decisions made by clinicians and patients. It was agreed that the ABN would link with the MHRA team with recommended areas of research and database requirements to be discussed between MHRA and NIHR/NHS Digital. The ABN Annual Meeting, rebranded for 2020 as ‘The Virtual Experience’ opened on 7 September and will run online until 16 November. … [1]: /embed/inline-graphic-1.gif

中文翻译：

---

荷兰银行新闻。

![图表][1] 在 7 月份发表 Cumberlege 评论后，ABN 与 June Raine 博士（MHRA 首席执行官）及其同事会面，讨论了下一步措施，包括开发丙戊酸盐登记册的可能性。MHRA 团队非常了解该主题。ABN 解释了研究的必要性，以更好地了解在服用丙戊酸盐期间怀孕的妇女所获得的信息，以及临床医生和患者做出决定的基础。同意 ABN 将与 MHRA 团队联系，推荐研究领域和数据库要求，以便在 MHRA 和 NIHR/NHS Digital 之间讨论。ABN 年会于 2020 年更名为“虚拟体验”，于 9 月 7 日开幕，并将在线运行至 11 月 16 日。… [1]：/embed/inline-graphic-1.gif